{
    "id": 11597,
    "fullName": "NTRK3 G623E",
    "impact": "missense",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "NTRK3 G623E lies within the protein kinase domain of the Ntrk3 protein (UniProt.org). G623E has been associated with resistance to tyrosine kinase inhibitors (PMID: 30093503) in the context of ETV6-NTRK3 fusion, but has not been biochemically characterized and therefore, its effect on Ntrk3 protein function is unknown (PubMed, Jan 2020).",
            "references": [
                {
                    "id": 12439,
                    "pubMedId": 30093503,
                    "title": "Repotrectinib (TPX-0005) Is a Next-Generation ROS1/TRK/ALK Inhibitor That Potently Inhibits ROS1/TRK/ALK Solvent- Front Mutations.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30093503"
                },
                {
                    "id": 285,
                    "pubMedId": null,
                    "title": null,
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 4916,
        "geneSymbol": "NTRK3",
        "terms": [
            "NTRK3",
            "gp145(trkC)",
            "GP145-TrkC",
            "TRKC"
        ]
    },
    "variant": "G623E",
    "createDate": "09/08/2015",
    "updateDate": "01/15/2020",
    "referenceTranscriptCoordinates": {
        "id": 149611,
        "transcript": "NM_001012338",
        "gDna": "chr15:g.87933033C>T",
        "cDna": "c.1868G>A",
        "protein": "p.G623E",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 14210,
            "approvalStatus": "Phase I",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase I (TRIDENT-1) trial, Repotrectinib (TPX-0005) treatment resulted in partial response in a patient with advanced solid tumor harboring NTRK3 G623E in the context of NTRK3 fusion (J Clin Oncol 36, 2018 (suppl; abstr 2513); NCT03093116).",
            "molecularProfile": {
                "id": 29954,
                "profileName": "NTRK3 fusion NTRK3 G623E"
            },
            "therapy": {
                "id": 3950,
                "therapyName": "Repotrectinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 11510,
                    "pubMedId": null,
                    "title": "A phase 1 study of the next-generation ALK/ROS1/TRK inhibitor ropotrectinib (TPX-0005) in patients with advanced ALK/ROS1/NTRK+ cancers (TRIDENT-1).",
                    "url": "https://meetinglibrary.asco.org/record/160189/abstract"
                }
            ],
            "ampCapAscoEvidenceLevel": "C",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 16332,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, Repotrectinib (TPX-0005) treatment resulted in partial response and tumor shrinkage in a patient with mammary analogue secretory carcinoma of the parotid gland harboring NTRK3 G623E in the context of ETV6-NTRK3, and the patient remained on treatment for over 17 months (PMID: 30093503; NCT03093116).",
            "molecularProfile": {
                "id": 31603,
                "profileName": "ETV6 - NTRK3 NTRK3 G623E"
            },
            "therapy": {
                "id": 3950,
                "therapyName": "Repotrectinib",
                "synonyms": null
            },
            "indication": {
                "id": 9036,
                "name": "parotid gland cancer",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 12439,
                    "pubMedId": 30093503,
                    "title": "Repotrectinib (TPX-0005) Is a Next-Generation ROS1/TRK/ALK Inhibitor That Potently Inhibits ROS1/TRK/ALK Solvent- Front Mutations.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30093503"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 16331,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, a patient with mammary analogue secretory carcinoma of the parotid gland harboring an ETV6-NTRK3 fusion developed progressive disease after initial response to Rozlytrek (entrectinib), and NTRK3 G623E was identified in the post-progression biopsy (PMID: 30093503).",
            "molecularProfile": {
                "id": 31603,
                "profileName": "ETV6 - NTRK3 NTRK3 G623E"
            },
            "therapy": {
                "id": 1455,
                "therapyName": "Entrectinib",
                "synonyms": null
            },
            "indication": {
                "id": 9036,
                "name": "parotid gland cancer",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 12439,
                    "pubMedId": 30093503,
                    "title": "Repotrectinib (TPX-0005) Is a Next-Generation ROS1/TRK/ALK Inhibitor That Potently Inhibits ROS1/TRK/ALK Solvent- Front Mutations.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30093503"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 16329,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Repotrectinib (TPX-0005) inhibited proliferation of transformed cells expressing NTRK3 G623E in the context of ETV6-NTRK3 in culture (PMID: 30093503).",
            "molecularProfile": {
                "id": 31603,
                "profileName": "ETV6 - NTRK3 NTRK3 G623E"
            },
            "therapy": {
                "id": 3950,
                "therapyName": "Repotrectinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 12439,
                    "pubMedId": 30093503,
                    "title": "Repotrectinib (TPX-0005) Is a Next-Generation ROS1/TRK/ALK Inhibitor That Potently Inhibits ROS1/TRK/ALK Solvent- Front Mutations.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30093503"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 11646,
            "profileName": "NTRK3 G623E",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 29954,
            "profileName": "NTRK3 fusion NTRK3 G623E",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 31603,
            "profileName": "ETV6 - NTRK3 NTRK3 G623E",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 149609,
            "transcript": "XM_017022254",
            "gDna": "chr15:g.87933033C>T",
            "cDna": "c.1868G>A",
            "protein": "p.G623E",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 149610,
            "transcript": "NM_002530",
            "gDna": "chr15:g.87933033C>T",
            "cDna": "c.1868G>A",
            "protein": "p.G623E",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 149608,
            "transcript": "XM_017022253",
            "gDna": "chr15:g.87933033C>T",
            "cDna": "c.1868G>A",
            "protein": "p.G623E",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 149611,
            "transcript": "NM_001012338",
            "gDna": "chr15:g.87933033C>T",
            "cDna": "c.1868G>A",
            "protein": "p.G623E",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 149612,
            "transcript": "XM_006720545",
            "gDna": "chr15:g.87933033C>T",
            "cDna": "c.1868G>A",
            "protein": "p.G623E",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 149613,
            "transcript": "XM_017022242",
            "gDna": "chr15:g.87933033C>T",
            "cDna": "c.1868G>A",
            "protein": "p.G623E",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 149606,
            "transcript": "XM_017022240",
            "gDna": "chr15:g.87933033C>T",
            "cDna": "c.1868G>A",
            "protein": "p.G623E",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 149607,
            "transcript": "XM_006720543",
            "gDna": "chr15:g.87933033C>T",
            "cDna": "c.1868G>A",
            "protein": "p.G623E",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}